Latest Insider Transactions at Mirion Technologies, Inc. (MIR)
This section provides a real-time view of insider transactions for Mirion Technologies, Inc. (MIR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Mirion Technologies, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Mirion Technologies, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2023
|
Lawrence D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,835
+4.81%
|
-
|
|
Dec 29
2023
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,075
+3.66%
|
-
|
|
Dec 29
2023
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,075
+3.66%
|
-
|
|
Dec 27
2023
|
Brian Schopfer Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,606
-5.39%
|
$86,060
$10.45 P/Share
|
|
Dec 27
2023
|
Thomas D Logan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
47,309
-6.73%
|
$473,090
$10.45 P/Share
|
|
Nov 01
2023
|
Michael J Rossi Medical Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,514
-4.53%
|
$33,084
$6.93 P/Share
|
|
Sep 29
2023
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,906
+5.24%
|
-
|
|
Sep 29
2023
|
Kenneth Bockhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,410
+6.26%
|
-
|
|
Sep 29
2023
|
Lawrence D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,570
+6.93%
|
-
|
|
Sep 29
2023
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,906
+5.24%
|
-
|
|
Jun 30
2023
|
Jody Markopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,340
+4.68%
|
-
|
|
Jun 30
2023
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,646
+5.06%
|
-
|
|
Jun 30
2023
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,646
+5.06%
|
-
|
|
Jun 30
2023
|
Kenneth Bockhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,340
+4.68%
|
-
|
|
Jun 06
2023
|
Sheila Rege Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+36.05%
|
-
|
|
Jun 06
2023
|
Lawrence D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+27.06%
|
-
|
|
Jun 06
2023
|
Kenneth Bockhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+20.74%
|
-
|
|
Jun 06
2023
|
Robert Cascella Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+27.06%
|
-
|
|
Jun 06
2023
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+20.12%
|
-
|
|
Jun 06
2023
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+20.12%
|
-
|
|
Jun 06
2023
|
Jody Markopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+20.74%
|
-
|
|
May 30
2023
|
Christopher A. Moore Chief Accounting Officer (PAO) |
SELL
Open market or private sale
|
Direct |
3,430
-9.63%
|
$24,010
$7.92 P/Share
|
|
May 23
2023
|
Christopher A. Moore Chief Accounting Officer (PAO) |
BUY
Grant, award, or other acquisition
|
Direct |
6,353
+15.13%
|
-
|
|
Apr 01
2023
|
Christopher A. Moore Chief Accounting Officer (PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
1,733
-5.59%
|
$13,864
$8.54 P/Share
|
|
Apr 01
2023
|
Brian Schopfer Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,451
-4.46%
|
$59,608
$8.54 P/Share
|
|
Apr 01
2023
|
Thomas D Logan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
36,862
-4.99%
|
$294,896
$8.54 P/Share
|
|
Mar 31
2023
|
Jody Markopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+6.42%
|
-
|
|
Mar 31
2023
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,596
+6.87%
|
-
|
|
Mar 31
2023
|
Kenneth Bockhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+6.42%
|
-
|
|
Mar 31
2023
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,596
+6.87%
|
-
|
|
Mar 29
2023
|
Christopher A. Moore Chief Accounting Officer (PAO) |
BUY
Grant, award, or other acquisition
|
Direct |
15,527
+33.36%
|
-
|
|
Mar 29
2023
|
Loic Eloy Technologies Group President |
BUY
Grant, award, or other acquisition
|
Direct |
16,645
+8.48%
|
-
|
|
Mar 29
2023
|
Michael J Rossi Medical Group President |
BUY
Grant, award, or other acquisition
|
Direct |
41,242
+25.31%
|
-
|
|
Mar 29
2023
|
Brian Schopfer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,689
+22.93%
|
-
|
|
Mar 29
2023
|
Thomas D Logan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
167,701
+18.49%
|
-
|
|
Mar 07
2023
|
Charterhouse General Partners (Ix) LTD |
SELL
Open market or private sale
|
Indirect |
9,786,153
-39.55%
|
$78,289,224
$8.64 P/Share
|
|
Mar 06
2023
|
Loic Eloy Technologies Group President |
SELL
Open market or private sale
|
Direct |
40,000
-23.55%
|
-
|
|
Dec 30
2022
|
Kenneth Bockhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,837
+8.35%
|
-
|
|
Dec 30
2022
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,208
+8.96%
|
-
|
|
Dec 30
2022
|
Jody Markopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,837
+8.35%
|
-
|
|
Dec 30
2022
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,208
+8.96%
|
-
|
|
Dec 27
2022
|
Thomas D Logan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,995
-5.45%
|
$197,970
$6.49 P/Share
|
|
Dec 27
2022
|
Brian Schopfer Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,606
-6.84%
|
$51,636
$6.49 P/Share
|
|
Dec 08
2022
|
Gsam Holdings LLC |
SELL
Open market or private sale
|
Indirect |
2,700
-100.0%
|
$16,200
$6.06 P/Share
|
|
Nov 01
2022
|
Michael J Rossi Medical Group President |
BUY
Grant, award, or other acquisition
|
Direct |
80,445
+50.0%
|
-
|
|
Sep 30
2022
|
Jody Markopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,641
+8.53%
|
-
|
|
Sep 30
2022
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,986
+9.22%
|
-
|
|
Sep 30
2022
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,986
+9.22%
|
-
|
|
Sep 30
2022
|
Kenneth Bockhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,641
+8.53%
|
-
|
|
Sep 16
2022
|
Sheila Rege Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,167
+50.0%
|
-
|